Risk of embryopathies with use of antithyroidal medications

Publikation: Bidrag til tidsskriftReview (oversigtsartikel)Forskningpeer review

OriginalsprogEngelsk
TidsskriftCurrent Opinion in Endocrinology, Diabetes and Obesity
Vol/bind24
Udgave nummer5
Sider (fra-til)364-371
Antal sider8
ISSN1752-296X
DOI
StatusUdgivet - 2017

Fingerprint

Fetal Diseases
Propylthiouracil
Pregnancy
Hyperthyroidism
Guidelines
Methimazole
Therapeutics
Observational Studies
Pregnant Women
Thyroid Gland
Mothers
Recurrence
Control Groups

Citer dette

@article{e204bfeb794b4dfeb91a585b231de803,
title = "Risk of embryopathies with use of antithyroidal medications",
keywords = "Journal Article",
author = "Andersen, {Stine L}",
year = "2017",
doi = "10.1097/MED.0000000000000353",
language = "English",
volume = "24",
pages = "364--371",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams & Wilkins, Ltd.",
number = "5",

}

Risk of embryopathies with use of antithyroidal medications. / Andersen, Stine L.

I: Current Opinion in Endocrinology, Diabetes and Obesity, Bind 24, Nr. 5, 2017, s. 364-371.

Publikation: Bidrag til tidsskriftReview (oversigtsartikel)Forskningpeer review

TY - JOUR

T1 - Risk of embryopathies with use of antithyroidal medications

AU - Andersen, Stine L

PY - 2017

Y1 - 2017

KW - Journal Article

U2 - 10.1097/MED.0000000000000353

DO - 10.1097/MED.0000000000000353

M3 - Review article

VL - 24

SP - 364

EP - 371

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 5

ER -